|
WO2021032884A1
|
|
Idh2 inhibition for producing t-cells and b-cells with a memory phenotype
|
|
EP3812396A1
|
|
Methods for treating and/or preventing hypersomnias
|
|
AU2019340475A1
|
|
Methods for modulating regulatory T cells and inhibiting tumor growth
|
|
WO2019202473A1
|
|
Ucp2 inducing agents for the treatment of cancer resistant to immune checkpoint blockade
|
|
CN111801325A
|
|
Pyrazole derivatives as inhibitors of Wnt signaling pathways
|
|
US10506368B1
|
|
Method and a system for matching subscriptions with publications
|
|
EP3593638A1
|
|
Fungicides to prevent and control fungal pathogens
|
|
US2020197432A1
|
|
Methods And Compositions For Controlling Cardiac Fibrosis And Remodeling
|
|
EP3575313A1
|
|
Insect corneal type nanocoatings
|
|
EP3324303A1
|
|
Method for segmenting and indexing features from multidimensional data
|
|
EP2705852A1
|
|
An immunogenic composition against Staphylococcus aureus comprising an inactivated recombinant non-pathogenic bacterium
|
|
EP2600886A1
|
|
Use of a peptide enhancing the ability of radiation therapy to kill cancer cells
|
|
CA2757114A1
|
|
Preparation of isolated agonist anti-edar monoclonal antibodies
|
|
EP2391378A1
|
|
Use of a fragment of rasgap peptide in the treatment or prevention of metastasis
|
|
EP2373686A2
|
|
Msp2 antigenic peptides and their use
|
|
EP2344641A2
|
|
Gene transfer vectors comprising at least one isolated dna molecule having insulator and or boundary properties and methods to identify the same
|
|
WO2010018545A1
|
|
Detection and use of pheromones
|
|
WO2009136370A1
|
|
Parenteral supplement with traceelemξntsfor treatment of i. a. sirs, burns selenium-defenciencies
|
|
EP2279490A1
|
|
Automatic detection and accurate segmentation of abdominal aortic aneurysm
|
|
US2011110979A1
|
|
Method and vaccine for optimizing the specific immune responses
|
